key: cord-0909214-ll0y4gpk
authors: Chandrashekar, Darshan S.; Manne, Upender; Varambally, Sooryanarayana
title: Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells
date: 2020-06-30
journal: bioRxiv
DOI: 10.1101/2020.06.24.169268
sha: 97e6a5f61fe8794ac96698d42352de7ac014d992
doc_id: 909214
cord_uid: ll0y4gpk

Understanding the molecular mechanism of SARS-CoV-2 infection (the cause of COVID-19) is a scientific priority for 2020. Various research groups are working toward development of vaccines and drugs, and many have published genomic and transcriptomic data related to this viral infection. The power inherent in publicly available data can be demonstrated via comparative transcriptome analyses. In the current study, we collected high-throughput gene expression data related to human lung epithelial cells infected with SARS-CoV-2 or other respiratory viruses (SARS, H1N1, rhinovirus, avian influenza, and Dhori) and compared the effect of these viruses on the human transcriptome. The analyses identified fifteen genes specifically expressed in cells transfected with SARS-CoV-2; these included CSF2 (colony-stimulating factor 2) and S100A8 and S100A9 (calcium-binding proteins), all of which are involved in lung/respiratory disorders. The analyses showed that genes involved in the Type1 interferon signaling pathway and the apoptosis process are commonly altered by infection of SARS-CoV-2 and influenza viruses. Furthermore, results of protein-protein interaction analyses were consistent with a functional role of CSF2 in COVID-19 disease. In conclusion, our analysis has revealed cellular genes associated with SARS-CoV-2 infection of the human lung epithelium; these are potential therapeutic targets.

P a g e | 2

Abstract:

Understanding the molecular mechanism of SARS-CoV-2 infection (the cause of COVID-19) is a scientific priority for 2020. Various research groups are working toward development of vaccines and drugs, and many have published genomic and transcriptomic data related to this viral infection. The power inherent in publicly available data can be demonstrated via comparative transcriptome analyses. In the current study, we collected high-throughput gene expression data related to human lung epithelial cells infected with SARS-CoV-2 or other respiratory viruses (SARS, H1N1, rhinovirus, avian influenza, and Dhori) and compared the effect of these viruses on the human transcriptome. The analyses identified fifteen genes specifically expressed in cells transfected with SARS-CoV-2; these included CSF2 (colonystimulating factor 2) and S100A8 and S100A9 (calcium-binding proteins), all of which are involved in lung/respiratory disorders. The analyses showed that genes involved in the Type1 interferon signaling pathway and the apoptosis process are commonly altered by infection of SARS-CoV-2 and influenza viruses. Furthermore, results of protein-protein interaction analyses were consistent with a functional role of CSF2 in COVID-19 disease. In conclusion, our analysis has revealed cellular genes associated with SARS-CoV-2 infection of the human lung epithelium; these are potential therapeutic targets.

Infection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of human coronavirus disease 2019 . The recent pandemic has caused devastation due to rapid spread of this viral infection. As a respiratory illness, the disease is readily transmitted. It also has a long incubation and can be carried asymptomatically, thus spreading through communities (1). The COVID-19 pandemic has affected almost every country regardless of their medical infrastructure and economic status. It has caused a healthcare crisis and created a devastating economic burden, including high unemployment, which has exacerbating the effect of the disease (2). At present, more than 9.4 million people from 213 countries have been infected with the virus [https://www.worldometers.info/coronavirus/]. The rapid spreading of this respiratory infection has forced millions to shelter in their homes and has led to death of more P a g e | 3

than 480,000 individuals. Additionally, COVID-19 disproportionately affects patients, particularly minorities in the U.S. and those with chronic problems such as hypertension, lung disease, diabetes, and immunocompromised conditions.

In the last three decades, the world has witnessed zoonotic transmission of various viruses (from animals to humans) leading to severe respiratory complications. These include H1N1, avian influenza, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome coronavirus (MERS CoV) (3, 4) . Although infections of these viruses is often fatal, their effect is restricted to geographic locations such as Africa, Asia, and South America. As the world awaits a vaccine for SARS-CoV-2, efforts are being made to understand the molecular mechanisms of these infections (5, 6).

High-throughput technologies such as RNA sequencing and microarrays are useful in the detection of respiratory virus infections and in understanding their molecular effect on human lung epithelial cells (7). Extensive data on corona virus sequencing has been deposited in public repositories such as NCBI Gene Expression Omnibus (GEO) and EMBL Array Express (8, 9) .

Meta-analysis and mining of such data can aid in a) understanding the molecular impact of COVID-19, b) elucidating differences and similarities between SARS-CoV-2 and other respiratory virus infections, and c) identification of targets for drug development. In the current study, we performed comparative analysis of publicly available gene expression data related to human lung epithelial cells infected with a respiratory virus. The analyses identified genes specifically expressed by SARS-CoV-2 infection and those that are commonly altered due to infection of coronovirus-2 and/or other respiratory viruses. In particular, expression of CSF2

(colony-stimulating factor 2) appears to be involved in COVID-19 disease.

RNA sequencing data analysis. GEO2R was used to identify differentially expressed genes for each of these studies independently (9). Probes with adj. P-value <0.05 and absolute fold change >=1.5 were considered as statistically significant and compared with DEGs of SARS-CoV-2 infection from RNA-seq data.

STRING, a database of known or predicted protein-protein interactions (PPIs) was used to obtain interactions between genes altered on SARS-CoV-2 infection (20). Output from the STRING database was uploaded to Cytoscape v3.7.2 in simple interaction format, and the Cytohubba app was employed to identify hub genes (21-23). The top 50 genes were obtained separately from the PPI network based on three network parameters (closeness, degree, and betweenness), then common genes among these were selected as hub genes. We also checked the DrugBank database to determine if a drug is available to target them (24).

Differential expression analysis was performed for NHBEC subjected to SARS-CoV-2 infection (n=3) or mock infection (n=3) from GSE147507. In total, 164 genes were up-regulated, and 76 genes were down-regulated by SARS-CoV-2 infection compared to mock infection [ Figure 1A ].

Gene Ontology enrichment analysis of differentially expressed genes showed "Type I interferon P a g e | 6

signaling pathway", "Inflammatory response", "Immune response", "Response to virus", and "Defense response to virus" as the top 5 enriched biological processes [ Figure 1B ].

The impact of other viral infections on the human lung epithelial cell transcriptome was explored using publicly available microarray data.

A search of microarray datasets in the NCBI GEO database led to identification of five studies involving human lung epithelial cells subjected to viral infection. GEO2R analyses of each study were performed separately identifying differentially expressed genes. Figure 1C shows DEGs 

Differentially expressed genes from SARS-CoV-2 RNA-seq data were compared with GEO2R analysis results of GSE47962, GSE17400, GSE48575, GSE49840, and GSE71766. There were 15 genes differentially expressed after infection of SARS-CoV-2 [ Figure 2A ]. TCIM, HEPHL1, TRIML2, S100A9, S100A8, CRCT1, MAB21L4, MRGPRX3, and CSF2 were up-regulated;

HNRNPUL2−BSCL2, CXCL14, THBD, GCNT4, PCDH7, and PADI3 were down-regulated.

Genes involved in "type1 interferon signaling pathway" and "apoptosis process" were commonly altered by SARS-CoV-2 and other viral infections. These included OAS1, OAS2, OAS3, MX1,

with Cytohubba plugin to identify hub genes. The top 50 genes were obtained based on three network parameters: degree, closeness, and betweenness separately. The 24 genes featured in all three lists were considered as hub genes [ Figure 4 ].

Microarray meta-analysis and comparative transcriptome analysis have been useful bioinformatic approaches for maximum utilization of publicly available gene expression data (25, 26) . Since the advent of high-throughput technologies such as microarrays and RNA-seq, researchers have performed in-depth transcriptome analysis of various biological conditions leading to multiple discoveries (27). Data from thousands of such experiments are being deposited in public repositories such as GEO and ArrayExpress. Selection and combinatorial analysis of such data can aid researchers in understanding the molecular mechanism of a disease, and in discovering biomarkers (28-30). We observed the availability of multiple microarray studies related to human respiratory viral infection and sensed the opportunity to compare the effect of SARS-CoV-2 and other respiratory viral infections on the human lung transcriptome.

The comparative transcriptome analysis led to identification of genes that are altered exclusively after SARS-CoV-2 infection. Among these genes, S100 calcium-binding proteinA9 (S100A9) and S100 calcium-binding protein A8 (S100A8) are calcium-and zinc-binding proteins that are elevated in inflammatory lung disorders (31). Colony stimulating factor 2 (CSF2) is a cytokinecoding gene associated with respiratory diseases such as pulmonary alveolar proteinosis (32).

Transcriptional and immune response regulator ( Almost all other hub genes were affected by infection of other respiratory viruses. In conclusion, both PPI analysis and comparative transcriptome analysis point to a role of CSF2 in the molecular mechanism of SARS-CoV-2 infections of human lung epithelium. The current study also highlights the exclusivity of known lung inflammation disorder genes such as S100A8 and S100A9 with respect to SARS-CoV-2 infection.

Although the current bioinformatics approach makes use of available data to identify molecular targets for treatment of COVID-19, we understand that experimental validation is necessary to establish the exclusive association of CSF2, S100A8, and S100A9 with SARS-CoV-2 infection. C  a  r  v  a  l  h  o  A  ,  C  e  z  a  r  o  t  t  i  F  i  l  h  o  M  L  ,  A  z  e  v  e  d  o  P  C  P  ,  S  i  l  v  e  i  r  a  F  i  l  h  o  R  N  ,  B  a  r  b  o  s  a  F  T  ,  R  o  c  h  a  T  J  M  ,  e  t  a  l  .  E  p  i  d  e  m  i  o  l  o  g  y  ,  d  i  a  g  n  o  s  i  s  ,  t  r  e  a  t  m  e  n  t  ,  a  n  d  f  u  t  u  r  e  p  e  r  s  p  e  c  t  i  v  e  s  c  o  n  c  e  r  n  i  n  g  S  A  R  S  -C  O  V  -2  :  a  r  e  v  i  e  w  a  r  t  i  c  l  e  .  R  e  v  A  s  s  o  c  M  e  d  B  r  a  s  (  1  9  9 2 ) . 2 0 2 0 ; 6 6 ( 3 ) : e  r  i  n  g  C  ,  J  e  n  s  e  n  L  J  ,  S  n  e  l  B  ,  H  o  o  p  e  r  S  D  ,  K  r  u  p  p  M  ,  F  o  g  l  i  e  r  i  n  i  M  ,  e  t  a  l  .  S  T  R  I  N  G  :  k  n  o  w  n  a  n  d  p  r  e  d  i  c  t  e  d  p  r  o  t  e  i  n  -p  r  o  t  e  i  n  a  s  s  o  c  i  a  t  i  o  n  s  ,  i  n  t  e  g  r  a  t  e  d  a  n  d  t  r  a  n  s  f  e  r  r  e  d  a  c  r  o  s  s  o  r  g  a  n  i  s  m  s  .  N  u  c  l  e  i  c  A  c  i  d  s  R  e  s  .  2  0  0  5  ;  3  3  (  D  a  t  a  b  a  s  e  i  s  s  u  e  )  :  D  4  3  3  -7  .  2  1  .  S  h  a  n  n  o  n  P  ,  M  a  r  k  i  e  l  A  ,  O  z  i  e  r  O  ,  B  a  l  i  g  a  N  S  ,  W  a  n  g  J  T  ,  R  a  m  a  g  e  D  ,  e  t  a  l  .  C  y  t  o  s  c  a  p  e  :  a  s  o  f  t  w  a  r  e  e  n  v  i  r  o  n  m  e  n  t  f  o  r  i  n  t  e  g  r  a  t  e  d  m  o  d  e  l  s  o  f  b  i  o  m  o  l  e  c  u  l  a  r  i  n  t  e  r  a  c  t  i  o  n  n  e  t  w  o  r  k  s  .  G  e  n  o  m  e  R  e  s  .  2  0  0  3  ;  1  3  (  1  1  ) : O  z  a  w  a  S  ,  K  a  t  o  Y  ,  K  o  m  o  r  i  R  ,  M  a  e  h  a  t  a  Y  ,  K  u  b  o  t  a  E  ,  H  a  t  a  R  .  B  R  A  K  /  C  X  C  L  1  4  e  x  p  r  e  s  s  i  o  n  s  u  p  p  r  e  s  s  e  s  t  u  m  o  r  g  r  o  w  t  h  i  n  v  i  v  o  i  n  h  u  m  a  n  o  r  a  l  c  a  r  c  i  n  o  m  a  c  e  l  l  s  .  B  i  o  c  h  e  m  B  i  o  p  h  y  s  R  e  s  C  o  m  m  u  n  .  2  0  0  6  ;  3  4  8  (  2  )  :  4  0  6  -1  2  .  4  0  .  A  u  g  s  t  e  n  M  ,  H  a  g  g  l  o  f  C  ,  O  l  s  s  o  n  E  ,  S  t  o  l  z  C  ,  T  s  a  g  o  z  i  s  P  ,  L  e  v  c  h  e  n  k  o  T  ,  e  t  a  l  .  C  X  C  L  1  4  i  s  a  n  a  u  t  o  c  r  i  n  e  g  r  o  w 

H1N1 & RV16-vs-Control (GSE71766) H1N1pdm-vs-Control (GSE48575) sH1N1-vs-Control (GSE48575)

DOHV-vs-Mock infection (GSE17400)

SARS-CoV-vs-Mock infection (GSE17400)

SARS-CoV-vs-Mock infection (GSE47962)

SARS-CoV-BAT-vs-Mock infection (GSE47962)

SARS-CoV-dORF6-vs-Mock infection (GSE47962) H1N1-vs-Mock infection (GSE47962)

H7N7-vs-Mock infection (GSE49840)

H5N1-vs-Mock infection (GSE49840)

H3N2-vs-Mock infection (GSE49840)

H7N9-vs-Mock infection (GSE49840)

Acknowledgment: This study was supported by UAB impact funds to UM and SV. We thank Dr. Donald Hill, of the UAB Comprehensive Cancer Center, for editing this manuscript.